Molecule Information
General Information of the Molecule (ID: Mol01068)
| Name |
Ribonuclease PH (RPH)
,Listeria monocytogenes
|
||||
|---|---|---|---|---|---|
| Synonyms |
RNase PH; tRNA nucleotidyltransferase; LMOf2365_1247
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
rph
|
||||
| Sequence |
MRVDGRESNALRNIEVTPDYLMHPEGSVLIASGNTKVICSASVETKVPPFMRGEGRGWIS
AEYSMLPRATNTRNIRESSKGKVTGRTMEIQRLIGRALRAVVDLDALGERTIWLDCDVIQ ADGGTRTASITGAFIAMVMAIAKLDEAVPFAKFPVKDFLAATSVGVLEEGGTVLDLNYVE DSAAQVDMNIIMTGSGAFVELQGTGEEATFSETELAELIALGKKGISELIEIQKETLGDK VTARIKGE Click to Show/Hide
|
||||
| Function |
Phosphorolytic 3'-5' exoribonuclease that plays an important role in tRNA 3'-end maturation. Removes nucleotide residues following the 3'-CCA terminus of tRNAs; can also add nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates, but this may not be physiologically important. Probably plays a role in initiation of 16S rRNA degradation (leading to ribosome degradation) during starvation.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
2 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: HIV-infected patients with tuberculosis [ICD-11: 1C60.0] | [1], [2], [3] | |||
| Resistant Disease | HIV-infected patients with tuberculosis [ICD-11: 1C60.0] | |||
| Resistant Drug | Rifampin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Escherichia coli TOP10 | 83333 | ||
| Bacillus cereus RPH-Bc | 1396 | |||
| Escherichia coli Rosetta(DE3) pLysS | 866768 | |||
| L. monocytogenes | 1639 | |||
| Experiment for Molecule Alteration |
Whole genome sequence assay | |||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation. | |||
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: MycoBacterial infection [ICD-11: 1B2Z.1] | [1], [2], [3] | |||
| Resistant Disease | MycoBacterial infection [ICD-11: 1B2Z.1] | |||
| Resistant Drug | Rifaximin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | Escherichia coli TOP10 | 83333 | ||
| Bacillus cereus RPH-Bc | 1396 | |||
| Escherichia coli Rosetta(DE3) pLysS | 866768 | |||
| L. monocytogenes | 1639 | |||
| Experiment for Molecule Alteration |
Whole genome sequence assay | |||
| Experiment for Drug Resistance |
MIC assay | |||
| Mechanism Description | RIF phosphotransferase (rph) led to the identification of a new resistance gene and associated enzyme responsible for inactivating rifamycin antibiotics by phosphorylation. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
